Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Choufi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Gynecologie, Obstetrique & Fertilite|July 21, 2006
[Polycythemia and fibromyoma. Case report]T Michy, B Choufi, G Le Bouëdec, et al.
Bulletin Du Cancer|October 18, 2001
[Allogeneic hematopoietic cell transplantation in solid tumors]J O Bay, B Choufi, O Tournilhac, et al.
Bone Marrow Transplantation|February 26, 2014
Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunityB Choufi, J Trauet, S Thiant, et al.
Bone Marrow Transplantation|March 29, 2000
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancerJ O Bay, B Choufi, C Pomel, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Pathologie-Biologie|June 8, 2014
[The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease]B Choufi, S Thiant, J Trauet, et al.
British Journal of Haematology|June 20, 1998
Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapyA Tchirkov, M Giollant, F Tavernier, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Leukemia|January 27, 2006
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaD Rea, L Legros, E Raffoux, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Gynecologie, Obstetrique & Fertilite|July 21, 2006
[Polycythemia and fibromyoma. Case report]T Michy, B Choufi, G Le Bouëdec, et al.
Bulletin Du Cancer|October 18, 2001
[Allogeneic hematopoietic cell transplantation in solid tumors]J O Bay, B Choufi, O Tournilhac, et al.
Bone Marrow Transplantation|February 26, 2014
Donor-derived CD4(+)/CCR7(+) T-cell partial selective depletion does not alter acquired anti-infective immunityB Choufi, J Trauet, S Thiant, et al.
Bone Marrow Transplantation|March 29, 2000
Potential allogeneic graft-versus-tumor effect in a patient with ovarian cancerJ O Bay, B Choufi, C Pomel, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Pathologie-Biologie|June 8, 2014
[The impact of donor naive and memory T cell subsets on patient outcome following allogeneic stem cell transplantation: relationship between infused donor CD4+/CCR7+ T cell subsets and acute graft-versus-host disease]B Choufi, S Thiant, J Trauet, et al.
British Journal of Haematology|June 20, 1998
Interphase cytogenetics and competitive RT-PCR for residual disease monitoring in patients with chronic myeloid leukaemia during interferon-alpha therapyA Tchirkov, M Giollant, F Tavernier, et al.
Bone Marrow Transplantation|February 1, 1997
rhGM-CSF vs placebo following rhGM-CSF-mobilized PBPC transplantation: a phase III double-blind randomized trialM Legros, J Fleury, J O Bay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1997
High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term resultsM Legros, J Dauplat, J Fleury, et al.
Leukemia|January 27, 2006
High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemiaD Rea, L Legros, E Raffoux, et al.
Pageof 2